Harrow HROW
NASDAQ HROW
$30.48 -0.13 (-0.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harrow (HROW) Cash & Equivalents (2010 - 2026)

Updated

Harrow (HROW) posted Cash & Equivalents of $83.89 million for Q2 2026, up 58.4% from $52.96 million a year earlier but down 11.4% from the prior quarter.

Analysis

Harrow (HROW) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Harrow's Cash & Equivalents came in at $72.93 million, up 54.4% from FY2024.

  • Annual Cash & Equivalents shows a five-year compound annual growth rate of 76.1% (FY2020 to FY2025).
  • In prior years, Harrow's Cash & Equivalents was $47.25 million in FY2024 (-36.2%), $74.09 million in FY2023 (-23.0%), $96.27 million in FY2022 (+128.3%) and $42.17 million in FY2021 (+880.4%).
  • Quarterly Cash & Equivalents has run from a low of $19.25 million in Q1 2023 to a high of $96.27 million in Q4 2022 over five years.
  • On a year-over-year basis, Cash & Equivalents has increased in each of the last four quarters, with growth averaging 12.9% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2021, with growth of 910.2%; the weakest was Q1 2023, with a decline of 54.1%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $94.64 million (Q1 2026), $72.93 million (Q4 2025) and $74.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Harrow 1.15 Bn 821.29 Mn 50.36 Mn 83.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 83.89 Mn
Mar 31, 2026 94.64 Mn
Dec 31, 2025 72.93 Mn
Sep 30, 2025 74.29 Mn
Jun 30, 2025 52.96 Mn
Mar 31, 2025 66.73 Mn
Dec 31, 2024 47.25 Mn
Sep 30, 2024 72.60 Mn
Jun 30, 2024 70.97 Mn
Mar 31, 2024 68.54 Mn
Dec 31, 2023 74.09 Mn
Sep 30, 2023 65.61 Mn
Jun 30, 2023 22.75 Mn
Mar 31, 2023 19.25 Mn
Dec 31, 2022 96.27 Mn
Sep 30, 2022 44.96 Mn
Jun 30, 2022 46.44 Mn
Mar 31, 2022 41.95 Mn
Dec 31, 2021 42.17 Mn
Sep 30, 2021 57.86 Mn
API Access

Harrow Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=HROW&period=max&api_key=YOUR_API_KEY